31.07.2013 • News

LyondellBasell Boosted by U.S. Polyolefins Business in Q2

In Q2 2013, sales of Rotterdam-based petrochemical and plastics giant LyondellBasell weakened by 1.3% year-on-year to $11.1 billion but improved by 4% against Q1 2013. EBITDA declined by 4% year-on-year, while increasing by the same margin against Q1. A strong performance by the US-based olefins and polyolefins segment is largely credited for the positive results. Business in Europe and Asia was better than expected, but CEO Jim Gallogly warned that pricing conventions and maintenance turnarounds at competitors had boosted quarterly figures. "Underlying fundamentals within Europe remain weak," he said. 

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Interview

Navigating Uncertainty and Driving Innovation
Meeting Pharma’s Demand for Speed, Reliability, and Flexibility

Navigating Uncertainty and Driving Innovation

Axplora CCO Arul Ramadurai discusses navigating industry uncertainty, building strategic partnerships, and advancing flexible pharmaceutical manufacturing

most read